Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1967-03-22 to 1967-04-05
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Study predating guidelines and GLP, but performed close to OECD TG 403.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1967
Report date:
1967

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 403 (Acute Inhalation Toxicity)
Deviations:
not applicable
Principles of method if other than guideline:
Based on H.F. Smyth et al.: Am. Ind. Hyg. Ass. J. 23, 95-107 (1962)
GLP compliance:
no
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
4-acetylmorpholine
EC Number:
216-913-4
EC Name:
4-acetylmorpholine
Cas Number:
1696-20-4
Molecular formula:
C6H11NO2
IUPAC Name:
1-(morpholin-4-yl)ethan-1-one
Details on test material:
- Name of test material: N-Acetylmorpholin

Test animals

Species:
rat
Strain:
not specified
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Two group weights at study initiation: 1280 g (28.03., 3 males / 3 females); 1325 g (29.03., 3 males / 3 females)

ENVIRONMENTAL CONDITIONS
- no data

IN-LIFE DATES: From: 1967-03-29 To: 1967-04-05

Administration / exposure

Route of administration:
inhalation: vapour
Type of inhalation exposure:
whole body
Vehicle:
air
Details on inhalation exposure:
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: not specified
- Exposure chamber volume: not specified
- Method of holding animals in test chamber: not specified
- Source and rate of air: not specified
- System of generating vapour: bubbling 200 L/h air through a substance column of about 5 cm above a fritted glass disc in a glass cylinder for 8 hours
- Temperature, humidity, pressure in air chamber: at 20°C, nothing else specified

TEST ATMOSPHERE
- Brief description of analytical method used: no analytical method used
- Samples taken from breathing zone: no

TEST ATMOSPHERE
- Particle size distribution: not applicable (vapour)
Analytical verification of test atmosphere concentrations:
no
Duration of exposure:
8 h
Concentrations:
Calculation from vapour pressure of test item:

Concentration = VP / TP * 1000000 * MW / MVo
= 0.022 / 1013 * 1000000 * 129.16 /22.414 = 125 mg/m³ or 0.125 mg/L air
Where:
- Vapour pressure (VP): 0.022 hPa
- Total pressure (TP): 1013 mm Hg
- Molecular weight (MW): 129.16
- MolVolume (MVo): 22.414


Nominal concentrations from raw data:
Group 1a.: 0.1685 g/L (269.54 g test item / 1600 L air)
Group 1b.: 0.1700 g/L (271.93 g test item / 1600 L air)
Group 2a.: 0.1374 g/L (219.87 g test item / 1600 L air)
Group 2b.: 0.1388 g/L (222.06 g test item / 1600 L air)

No. of animals per sex per dose:
12 males, 12 females
Control animals:
no
Details on study design:
two groups (6 males, 6 females each) exposed for 8h each
Group 1: 28. 3.1967
Group 2: 29. 3.1967
- Duration of observation period following administration: 7 days
- Frequency of observations and weighing: body weight taken at study start and end
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs (groupwise)
Statistics:
not performed

Results and discussion

Preliminary study:
Considering the relatively low vapour pressure of 0.022 mg Hg at 20°C, the calculated test item concentration of 170 mg/L air was implausibly high. The saturated atmospere calculated from the vapour pressure is 1.7 mg/L.
Effect levels
Sex:
male/female
Dose descriptor:
LC0
Effect level:
> 0.125 mg/L air (nominal)
Based on:
test mat.
Exp. duration:
8 h
Remarks on result:
other: Calculated from vapour pressure (0.027 hPa at 20°C)
Mortality:
No mortality occurred
Clinical signs:
other: None
Body weight:
Both groups gained body weight between day 1 and day 7:
Total group 1, day 1: 1280 g; day 7: 1415 g
Total group 2, day 1: 1325 g; day 7: 1433 g
Gross pathology:
chronic bronchitis (1x)
Other findings:
None

Any other information on results incl. tables

No mortalities after 8-hour exposure to an atmosphere enriched with the substance at 20°C.

Applicant's summary and conclusion